USE OF PLATELET GLYCOPEPTIDE IIIA EPITOPES IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA

Stanislaw Urbaniak (Inventor), Robert Norman Barker (Inventor), Hosea M. Sukati (Inventor)

Research output: Patent

2 Downloads (Pure)

Abstract

The present invention relates to a composition for treating diseases associated with autoantibodies specific for platelet proteins, in particular autoimmune thrombocytopenic purpura. The composition, comprising an epitope of a platelet protein, treats diseases by tolerisation.
Original languageEnglish
Patent numberEP2120992
IPCA61K38/10; A61P7/00
Priority date18/01/07
Publication statusPublished - 27 Mar 2013

Fingerprint

Idiopathic Thrombocytopenic Purpura
Glycopeptides
Epitopes
Blood Platelets
Autoantibodies
Proteins

Cite this

Urbaniak, S., Barker, R. N., & Sukati, H. M. (2013). IPC No. A61K38/10; A61P7/00. USE OF PLATELET GLYCOPEPTIDE IIIA EPITOPES IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA. (Patent No. EP2120992).

USE OF PLATELET GLYCOPEPTIDE IIIA EPITOPES IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA. / Urbaniak, Stanislaw (Inventor); Barker, Robert Norman (Inventor); Sukati, Hosea M. (Inventor).

IPC No.: A61K38/10; A61P7/00. Patent No.: EP2120992.

Research output: Patent

Urbaniak, S, Barker, RN & Sukati, HM 2013, USE OF PLATELET GLYCOPEPTIDE IIIA EPITOPES IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA, Patent No. EP2120992, IPC No. A61K38/10; A61P7/00.
Urbaniak S, Barker RN, Sukati HM, inventors. USE OF PLATELET GLYCOPEPTIDE IIIA EPITOPES IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA. A61K38/10; A61P7/00. 2013 Mar 27.
Urbaniak, Stanislaw (Inventor) ; Barker, Robert Norman (Inventor) ; Sukati, Hosea M. (Inventor). / USE OF PLATELET GLYCOPEPTIDE IIIA EPITOPES IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA. IPC No.: A61K38/10; A61P7/00. Patent No.: EP2120992.
@misc{79091430d08640809e7233580600c7e9,
title = "USE OF PLATELET GLYCOPEPTIDE IIIA EPITOPES IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA",
abstract = "The present invention relates to a composition for treating diseases associated with autoantibodies specific for platelet proteins, in particular autoimmune thrombocytopenic purpura. The composition, comprising an epitope of a platelet protein, treats diseases by tolerisation.",
author = "Stanislaw Urbaniak and Barker, {Robert Norman} and Sukati, {Hosea M.}",
year = "2013",
month = "3",
day = "27",
language = "English",
type = "Patent",
note = "EP2120992; A61K38/10; A61P7/00",

}

TY - PAT

T1 - USE OF PLATELET GLYCOPEPTIDE IIIA EPITOPES IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA

AU - Urbaniak, Stanislaw

AU - Barker, Robert Norman

AU - Sukati, Hosea M.

PY - 2013/3/27

Y1 - 2013/3/27

N2 - The present invention relates to a composition for treating diseases associated with autoantibodies specific for platelet proteins, in particular autoimmune thrombocytopenic purpura. The composition, comprising an epitope of a platelet protein, treats diseases by tolerisation.

AB - The present invention relates to a composition for treating diseases associated with autoantibodies specific for platelet proteins, in particular autoimmune thrombocytopenic purpura. The composition, comprising an epitope of a platelet protein, treats diseases by tolerisation.

M3 - Patent

M1 - EP2120992

ER -